Specifically, MLN4924 inhibits the activities of CRL/SCF E3 ubiquitin ligases, involving skp2 and CRL4, thus accumulating p21 and promoting senescence in CRC, lung cancer, glioblastoma, and lymphoma [102–104]. Here, IL17RB is linked to colorectal carcinoma.